Home / Sweden / Immunovia AB (publ)
Immunovia AB (publ)
Short position disclosed on September 3, 2026.
Evolution of the disclosed total
February 18, 2021 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Two Sigma Investments, LP | 0.58% | new | September 3, 2026 |
In the United States IMMVF (OTC): 2,126,315 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Immunovia AB (publ) Titelia
Get the moves on Immunovia AB (publ) by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 6, 2021 | Voleon Capital Management LP | 0.70% | |
| March 25, 2021 | Voleon Capital Management LP | 0.60% | |
| March 12, 2021 | Voleon Capital Management LP | 0.57% | |
| February 22, 2021 | Voleon Capital Management LP | 0.60% | |
| February 18, 2021 | Voleon Capital Management LP | 0.54% |
Download 55 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.10% of the capital sold short
- Elekta AB (publ) 9.09% of the capital sold short
- JM AB 7.61% of the capital sold short
- Bonesupport Holding AB 6.91% of the capital sold short
- Truecaller AB 6.88% of the capital sold short
- Hemnet Group AB (publ) 6.55% of the capital sold short
- RaySearch Laboratories AB (publ) 4.96% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Dynavox Group AB 4.88% of the capital sold short
- Aktiebolaget Electrolux 4.41% of the capital sold short
- AAK AB (publ) 4.31% of the capital sold short
- Hexatronic Group AB 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Immunovia AB (publ), source Finansinspektionen, data as at September 3, 2026, https://www.quivad.com/action/immunovia-ab-publ?page=2